EE+ POEM Archive
Abelacimab has fewer bleeds than rivaroxaban, but study has several important biases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Abelacimab Has Fewer Bleeds Than Rivaroxaban, but Study Has Several Important Biases." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377331/all/Abelacimab_has_fewer_bleeds_than_rivaroxaban__but_study_has_several_important_biases.
Abelacimab has fewer bleeds than rivaroxaban, but study has several important biases. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377331/all/Abelacimab_has_fewer_bleeds_than_rivaroxaban__but_study_has_several_important_biases. Accessed March 24, 2025.
Abelacimab has fewer bleeds than rivaroxaban, but study has several important biases. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377331/all/Abelacimab_has_fewer_bleeds_than_rivaroxaban__but_study_has_several_important_biases
Abelacimab Has Fewer Bleeds Than Rivaroxaban, but Study Has Several Important Biases [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377331/all/Abelacimab_has_fewer_bleeds_than_rivaroxaban__but_study_has_several_important_biases.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Abelacimab has fewer bleeds than rivaroxaban, but study has several important biases
ID - 3377331
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377331/all/Abelacimab_has_fewer_bleeds_than_rivaroxaban__but_study_has_several_important_biases
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
